CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
T-cell immunoglobulin domain and mucin domain-3 (TIM-3, also known as HAVCR2) is an activation-induced inhibitory molecule involved in tolerance and shown to induce T-cell exhaustion in chronic viral infection and cancers. Under some conditions, TIM-3 expression has also been shown to be stimulatory. Considering that TIM-3, like cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death 1 (PD-1), is being targeted for cancer immunotherapy, it is important to identify the circumstances under which TIM-3 can inhibit and activate T-cell responses. Here we show that TIM-3 is co-expressed and forms a heterodimer with carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1), another well-known molecule expressed on activated T cells and involved in T-cell inhibition. Biochemical, biophysical and X-ray crystallography studies show that the membrane-distal immunoglobulin-variable (IgV)-like amino-terminal domain of each is crucial to these interactions. The presence of CEACAM1 endows TIM-3 with inhibitory function. CEACAM1 facilitates the maturation and cell surface expression of TIM-3 by forming a heterodimeric interaction in cis through the highly related membrane-distal N-terminal domains of each molecule. CEACAM1 and TIM-3 also bind in trans through their N-terminal domains. Both cis and trans interactions between CEACAM1 and TIM-3 determine the tolerance-inducing function of TIM-3. In a mouse adoptive transfer colitis model, CEACAM1-deficient T cells are hyper-inflammatory with reduced cell surface expression of TIM-3 and regulatory cytokines, and this is restored by T-cell-specific CEACAM1 expression. During chronic viral infection and in a tumour environment, CEACAM1 and TIM-3 mark exhausted T cells. Co-blockade of CEACAM1 and TIM-3 leads to enhancement of anti-tumour immune responses with improved elimination of tumours in mouse colorectal cancer models. Thus, CEACAM1 serves as a heterophilic ligand for TIM-3 that is required for its ability to mediate T-cell inhibition, and this interaction has a crucial role in regulating autoimmunity and anti-tumour immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interaction between TIM-3 and its four ligands (galectin 9, high mobility group protein B1, phosphatidyl serine, and carcinoembryonic antigen cell adhesion molecule 1) can diminish anti-tumor immunity through a variety of mechanisms including inducing CD8+ T cell death and exhaustion (Huang et al., 2015).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Huang et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We stimulated primary microglia with galectin-9 and CEACAM1, both of which mediate TIM-3 function in T cells by phosphorylating Y256 and Y263 residues34,35. This treatment had no effect on pSMAD2 expression”
From Immune checkpoint TIM-3 regulates microglia and Alzheimer’s disease (2025) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 2×
“MolecularreplacementwasperformedwithMolrep,refinementswereperformedwithPHENIX 42 and intermittent model building was performed with COOT 43 , as described above.”
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716 · cited 4×
“MolecularreplacementwasperformedwithMolrep,refinementswereperformedwithPHENIX 42 and intermittent model building was performed with COOT 43 , as described above.”
InfluentialHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Multiple Sequence Alignment Using ClustalW and ClustalX
Thompson, J. D., Gibson, T. J., & Higgins, D. G. (2003) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0203s00 · Cited by 2,971 · cited 1×
“In addition, multiple sequencealignmentswereperformedusingClustalW 45 .”
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM
Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R., & Leslie, A. G. W. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910048675 · Cited by 2,860 · cited 2×
“ThedatawereprocessedwithMosflm 40 andthe CCP 4softwaresuite 41 .”
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
Sakuishi, K., Apetoh, L., Sullivan, J. M., Blazar, B. R., Kuchroo, V. K., & Anderson, A. C. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100643 · Cited by 2,072
Self-citationThe inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066 · cited 1×
“…Ebi3 , IL-27p28 (also known as Il27 ) and IL-12p35 (also known as Il12a ) encoding the regulatorycytokinesIL-27andIL-35(refs20,21)in Ceacam1 2 / 2 Rag2 2 / 2 recipients of CD4 1 T cells from Tim3 Tg relative to wild-type mice, and theirabsenceinrecipientsof Ceacam1 2 / 2 or…”
Self-citationThe Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057 · cited 2×
“Mouse T-cell lymphoma cells predicted to possess a novelTIM-3ligandexpressedCEACAM1(refs13,15)(ExtendedData Fig.”
Self-citationClassification of Inflammatory Bowel Disease
Lennard-Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,011 · cited 1×
“Thepatientswereclassifiedaccordingtoclinical,radiological,histologicalandendoscopic(thatis,typeanddistributionoflesions) accordingtoacceptedcriteria 48,49 .”
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Self-citationPowrie, F., Leach, M. W., Mauze, S., Caddie, L. B., & Coffman, R. L. (1993) · International Immunology · doi:10.1093/intimm/5.11.1461 · Cited by 1,078 · cited 1×
“MousemodelofIBD 53 .”
Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
Kearney, E. R., Pape, K. A., Loh, D. Y., & Jenkins, M. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90084-1 · Cited by 946
Jones, R. B., Ndhlovu, L. C., Barbour, J. D., Sheth, P. M., Jha, A. R., Long, B. R., Wong, J. C., Satkunarajah, M., Schweneker, M., Chapman, J. M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081398 · Cited by 753
Self-citationPaneth cells as a site of origin for intestinal inflammation
Adolph, T. E., Tomczak, M. F., Niederreiter, L., Ko, H.-J., Böck, J., Martinez-Naves, E., Glickman, J. N., Tschurtschenthaler, M., Hartwig, J., Hosomi, S., et al. (2013) · Nature · doi:10.1038/nature12599 · Cited by 732
Self-citationSánchez-Fueyo, A., Tian, J., Picarella, D., Domenig, C., Zheng, X. X., Sabatos, C. A., Manlongat, N., Bender, O., Kamradt, T., Kuchroo, V. K., et al. (2003) · Nature Immunology · doi:10.1038/ni987 · Cited by 712
Self-citationNeufert, C., Becker, C., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.279 · Cited by 675
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., et al. (2011) · Nature · doi:10.1038/nature09976 · Cited by 645
Self-citationSabatos, C. A., Chakravarti, S., Cha, E., Schubart, A., Sánchez-Fueyo, A., Zheng, X. X., Coyle, A. J., Strom, T. B., Freeman, G. J., & Kuchroo, V. K. (2003) · Nature Immunology · doi:10.1038/ni988 · Cited by 628
Self-citationThe RosettaDock server for local protein-protein docking
Lyskov, S., & Gray, J. J. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn216 · Cited by 592 · cited 1×
“TheROSIEDock-ingServerwasusedtoanalysethedocking(http://rosettadock.graylab.jhu.edu/ documentation/docking) 46,47 .”
CEACAM1: contact-dependent control of immunity
Gray-Owen, S. D., & Blumberg, R. S. (2006) · Nature Reviews Immunology · doi:10.1038/nri1864 · Cited by 537 · cited 1×
“…Ceacam1-4L Tg Ceacam1 2 / 2 mice 6 or Ceacam1-4S Tg Ceacam1 2 / 2 mice 10 (transgenic mice in which CEACAM1 isoforms containing a long (L) or short(S) cytoplasmic tail, respectively, are conditionally overexpressed in T cells) 7 (Extended Data Fig.”
Self-citationPractically Useful: What the R osetta Protein Modeling Suite Can Do for You
Kaufmann, K. W., Lemmon, G. H., DeLuca, S. L., Sheehan, J. H., & Meiler, J. (2010) · Biochemistry · doi:10.1021/bi902153g · Cited by 402
Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E. A., Sobel, R. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2871 · Cited by 394
Self-citationHuang, A. Y., Gulden, P. H., Woods, A. S., Thomas, M. C., Tong, C. D., Wang, W., Engelhard, V. H., Pasternack, G., Cotter, R., Hunt, D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9730 · Cited by 388
Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction
Jeon, M.-S., Atfield, A., Venuprasad, K., Krawczyk, C., Sarao, R., Elly, C., Yang, C., Arya, S., Bachmaier, K., Su, L., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.013 · Cited by 348
Krawczak, M., Nikolaus, S., von Eberstein, H., Croucher, P. J. P., El Mokhtari, N. E., & Schreiber, S. (2006) · Public Health Genomics · doi:10.1159/000090694 · Cited by 337
TIM‐3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
Hastings, W. D., Anderson, D. E., Kassam, N., Koguchi, K., Greenfield, E. A., Kent, S. C., Zheng, X. X., Strom, T. B., Hafler, D. A., & Kuchroo, V. K. (2009) · European Journal of Immunology · doi:10.1002/eji.200939274 · Cited by 333
Self-citationNeisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes
Boulton, I. C., & Gray-Owen, S. D. (2002) · Nature Immunology · doi:10.1038/ni769 · Cited by 322
Tracking epitope-specific T cells
Moon, J. J., Chu, H. H., Hataye, J., Pagán, A. J., Pepper, M., McLachlan, J. B., Zell, T., & Jenkins, M. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.9 · Cited by 288 · cited 1×
“For invivo trackingofOVA-specific antigen-specific T-cell responses, adoptive transfer experiments were performed on the basis of previous studies 27 .”
Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
Lee, J., Su, E. W., Zhu, C., Hainline, S., Phuah, J., Moroco, J. A., Smithgall, T. E., Kuchroo, V. K., & Kane, L. P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05297-11 · Cited by 285 · cited 1×
“Bothwild-typeand Ceacam1 2 / 2 T-celltransductantswithamTIM-3cytoplasmictaildeletion construct (TIM-3 D 252–281 ) 17,18 wereunresponsivetoanti-CD3stimulationorNFc fusion protein ligation (Fig.”
Self-citationTim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells
Dardalhon, V., Anderson, A. C., Karman, J., Apetoh, L., Chandwaskar, R., Lee, D. H., Cornejo, M., Nishi, N., Yamauchi, A., Quintana, F. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903275 · Cited by 278
Self-citationHirahara, K., Ghoreschi, K., Yang, X.-P., Takahashi, H., Laurence, A., Vahedi, G., Sciumè, G., Hall, A. O., Dupont, C. D., Francisco, L. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.024 · Cited by 254
Self-citationSignaling through OX40 (CD134) breaks peripheral T-cell tolerance
Bansal-Pakala, P., Gebre-Hiwot Jember, A., & Croft, M. (2001) · Nature Medicine · doi:10.1038/90942 · Cited by 230 · cited 1×
“ForOVAantigen-specificT-celltoleranceinduction,high-doseOVAantigenwasusedandmodifiedaccordingtopreviousstudies 11,25,26 .”
Promotion of colorectal neoplasia in experimental murine ulcerative colitis.
Okayasu, I., Ohkusa, T., Kajiura, K., Kanno, J., & Sakamoto, S. (1996) · Gut · doi:10.1136/gut.39.1.87 · Cited by 230
Cao, E., Zang, X., Ramagopal, U. A., Mukhopadhaya, A., Fedorov, A., Fedorov, E., Zencheck, W. D., Lary, J. W., Cole, J. L., Deng, H., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.016 · Cited by 228
Persons, D. A., Allay, J. A., Allay, E. R., Smeyne, R. J., Ashmun, R. A., Sorrentino, B. P., & Nienhuis, A. W. (1997) · Blood · doi:10.1182/blood.v90.5.1777 · Cited by 222 · cited 1×
“Fortransduction ofmouseprimaryCD4 1 Tcells,previouslydescribedmouseTIM-3anditsmutant expressingretroviruseswerepreparedinHEK293Tcellsusingecoand gag / pol viral envelope constructs (Clontech Inc.) 17,37,38 .”
Hung, A. C. F. (1996) · Medical Entomology and Zoology · Cited by 206
Course and prognosis of Crohn's disease.
Truelove, S. C., & Pena, A. S. (1976) · Gut · doi:10.1136/gut.17.3.192 · Cited by 174 · cited 1×
“Thepatientswereclassifiedaccordingtoclinical,radiological,histologicalandendoscopic(thatis,typeanddistributionoflesions) accordingtoacceptedcriteria 48,49 .”
SHP1 Phosphatase-Dependent T Cell Inhibition by CEACAM1 Adhesion Molecule Isoforms
Nagaishi, T., Pao, L. I., Lin, S.-H., Iijima, H., Kaser, A., Qiao, S., Chen, Z., Glickman, J. N., Najjar, S. M., Nakajima, A., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.026 · Cited by 169
Self-citationRapid analysis of T-cell selection in vivo using T cell–receptor retrogenic mice
Holst, J., Vignali, K. M., Burton, A. R., & Vignali, D. A. A. (2006) · Nature Methods · doi:10.1038/nmeth858 · Cited by 160 · cited 1×
“Fortransduction ofmouseprimaryCD4 1 Tcells,previouslydescribedmouseTIM-3anditsmutant expressingretroviruseswerepreparedinHEK293Tcellsusingecoand gag / pol viral envelope constructs (Clontech Inc.) 17,37,38 .”
Phospholipase Cγ1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE
Ye, K., Aghdasi, B., Luo, H. R., Moriarity, J. L., Wu, F. Y., Hong, J. J., Hurt, K. J., Bae, S. S., Suh, P.-G., & Snyder, S. H. (2002) · Nature · doi:10.1038/415541a · Cited by 158
Leung, N., Turbide, C., Olson, M., Marcus, V., Jothy, S., & Beauchemin, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209541 · Cited by 118 · cited 1×
“Ceacam1 2 / 2 mice (C57BL/6 and BALB/c backcrosses) were generated by N. Beauchemin 24 .”
Self-citationCrystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family
Tan, K. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2076 · Cited by 113
Morales, V. M., Christ, A. D., Watt, S. M., Kim, H. S., Johnson, K. W., Utku, N., Texieira, A. M., Mizoguchi, A., Mizoguchi, E., Russell, G. J., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1363 · Cited by 110 · cited 1×
“S.B.’slaboratory 32,33 Canada).”
Self-citationSpecific Regulation of T Helper Cell 1–mediated Murine Colitis by CEACAM1
Iijima, H., Neurath, M. F., Nagaishi, T., Glickman, J. N., Nieuwenhuis, E. E., Nakajima, A., Chen, D., Fuss, I. J., Utku, N., Lewicki, D. N., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030437 · Cited by 109
Self-citationWatt, S. M. (2001) · Blood · doi:10.1182/blood.v98.5.1469 · Cited by 107
Chen, D., Iijima, H., Nagaishi, T., Nakajima, A., Russell, S., Raychowdhury, R., Morales, V., Rudd, C. E., Utku, N., & Blumberg, R. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3535 · Cited by 89
Self-citationChen, C.-J., & Shively, J. E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3544 · Cited by 71
Gallagher, T. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3129-3137.1997 · Cited by 69
Chen, L., Chen, Z., Baker, K., Halvorsen, E. M., da Cunha, A. P., Flak, M. B., Gerber, G. K., Huang, Y.-H., Hosomi, S., Arthur, J. C., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.07.016 · Cited by 51
Self-citationSeeking significance in three-dimensional protein structure comparisons
Mizuguchi, K., & Gō, N. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80100-6 · Cited by 49
Patel, P. C., Lee, H. S. W., Ming, A. Y. K., Rath, A., Deber, C. M., Yip, C. M., Rocheleau, J. V., & Gray‐Owen, S. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.504639 · Cited by 46
Smith, A. L., Cardellichio, C. B., Winograd, D. F., Souza, M. S., Barthold, S. W., & Holmes, K. V. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/163.4.879 · Cited by 44
Zhang, X., Schwartz, J.-C. D., Almo, S. C., & Nathenson, S. G. (2002) · Protein Expression and Purification · doi:10.1006/prep.2002.1616 · Cited by 38 · cited 2×
“5, 0.4M arginine-HCl, 2mM EDTA, 5mM cysteamine and 0.5mM cystamine, as reported previously 39 .”
Cited by
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229
“Recent studies showed that TIM-3 is co-expressed with and binds to CECAM1 and that this interaction is important in TIM-30s regulatory function (Huang et al., 2015).”
BackgroundFundamental Mechanisms of Immune Checkpoint Blockade Therapy
Wei, S. C., Duffy, C. R., & Allison, J. P. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0367 · Cited by 3,088
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
“Lag-3 structurally resembles the CD4 co-receptor and, indeed, binds to MHC class II with a higher affinity than CD4 (Figure 1A; Huard et al., 1995).”
BackgroundSelf-citationHallmarks of response, resistance, and toxicity to immune checkpoint blockade
Morad, G., Helmink, B. A., Sharma, P., & Wargo, J. A. (2021) · Cell · doi:10.1016/j.cell.2021.09.020 · Cited by 1,648
Koyama, S., Akbay, E. A., Li, Y. Y., Herter-Sprie, G. S., Buczkowski, K. A., Richards, W. G., Gandhi, L., Redig, A. J., Rodig, S. J., Asahina, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10501 · Cited by 1,580
“CEACAM1 and phosphatidylserine have also been proposed as ligands for TIM-3 (refs 22,23).”
Background
Metadata
- Authors
- Huang, Y.-H., Zhu, C., Kondo, Y., Anderson, A. C., Gandhi, A., Russell, A., Dougan, S. K., Petersen, B.-S., Melum, E., Pertel, T., Clayton, K. L., Raab, M., Chen, Q., Beauchemin, N., Yazaki, P. J., Pyzik, M., Ostrowski, M. A., Glickman, J. N., Rudd, C. E., Ploegh, H. L., Franke, A., Petsko, G. A., Kuchroo, V. K., & Blumberg, R. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Brandeis University (US)
- Massachusetts Institute of Technology (US)
- Christian-Albrechts-Universität zu Kiel (DE)
- Oslo University Hospital (NO)
- University of Toronto (CA)
- University of Cambridge (GB)
- Sichuan University (CN)
- McGill University (CA)
- City Of Hope National Medical Center (US)
- St. Michael's Hospital (CA)
- Corresponding author
- Blumberg, Richard S.
- ORCID
- Venue
- Nature
- Published
- 2014-10-26
- Volume
- 517
- Issue
- 7534
- Pages
- 386-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4297519
- OpenAlex
- W2122730216
- Cited by
- 717
- References
- 58
- Citations by year
- 2026: 44 · 2025: 72 · 2024: 85 · 2023: 82 · 2022: 71 · 2021: 82 · 2020: 76 · 2019: 51 · 2018: 47 · 2017: 40 · 2016: 38 · 2015: 28
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR001102)
- National Institute of General Medical Sciences (R01GM032415, T32GM007122, GM-32415, R37GM032415, P41GM111244, R01GM026788)
- National Institute of Allergy and Infectious Diseases (AI 056299, P01AI073748, AI039671, AI073748, P01AI056299, P01AI039671)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK044319, DK0034854, R01DK053056, DK088199, DK053056, R56DK053056, DK051362, R37DK044319, R01DK051362, P30DK034854, R01DK044319, R01DK088199)
- National Institute of Neurological Disorders and Stroke (NS045937, R01NS045937)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- TIM-3, T cell exhaustion, immune tolerance, immune checkpoint, T cell co-inhibition, T cell costimulation, colorectal cancer, antitumor immunity, T cell receptor signaling
- MeSH terms
- Hepatitis A Virus Cellular Receptor 2, Animals, Cell Line, Disease Models, Animal, Female, Humans, Immune Tolerance, Inflammation, Ligands, Male, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Models, Molecular, Mucous Membrane, Protein Conformation, Receptors, Virus, T-Lymphocytes, Colorectal Neoplasms, Autoimmunity, Antigens, CD, Cell Adhesion Molecules, Mice, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.